pki-402 and Triple-Negative-Breast-Neoplasms

pki-402 has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for pki-402 and Triple-Negative-Breast-Neoplasms

Article	Year
Identification of effective natural PIK3CA H1047R inhibitors by computational study. Aging, 2021, 08-20, Volume: 13, Issue:16 Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with a poor prognosis and a high recurrence rate. Topics: Binding Sites; Class I Phosphatidylinositol 3-Kinases; Computational Biology; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Ligands; Models, Molecular; Mutation, Missense; Phenylurea Compounds; Pyrimidines; Signal Transduction; Triple Negative Breast Neoplasms; Wortmannin	2021

Article

Year

Identification of effective natural PIK3CA H1047R inhibitors by computational study.

Aging, 2021, 08-20, Volume: 13, Issue:16

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with a poor prognosis and a high recurrence rate.

Topics: Binding Sites; Class I Phosphatidylinositol 3-Kinases; Computational Biology; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Ligands; Models, Molecular; Mutation, Missense; Phenylurea Compounds; Pyrimidines; Signal Transduction; Triple Negative Breast Neoplasms; Wortmannin

2021